Working…
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT01763164
Brief Title: Study Comparing the Efficacy of MEK162 Versus Dacarbazine in Unresectable or Metastatic NRAS Mutation-positive Melanoma

First Submitted : January 4, 2013
First Submitted that Met QC Criteria : January 4, 2013
First Posted : January 8, 2013 (Estimate)

Certification/Extension First Submitted : September 30, 2016
Certification/Extension First Submitted that Met QC Criteria : September 30, 2016
Certification/Extension First Posted : October 3, 2016 (Estimate)

Last Update Submitted that Met QC Criteria : August 30, 2019
Last Update Posted : September 10, 2019